Cargando…

Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis

CONTEXT: Pre-clinical evidence suggests that prolactin has important metabolic functions in pregnancy and postpartum, in addition to lactogenic actions. OBJECTIVE: To explore the relationship between prolactin and maternal metabolic outcomes in human pregnancy and postpartum, particularly in relatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rassie, Kate, Giri, Rinky, Joham, Anju E., Mousa, Aya, Teede, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813437/
https://www.ncbi.nlm.nih.gov/pubmed/36619539
http://dx.doi.org/10.3389/fendo.2022.1069625
_version_ 1784863919716696064
author Rassie, Kate
Giri, Rinky
Joham, Anju E.
Mousa, Aya
Teede, Helena
author_facet Rassie, Kate
Giri, Rinky
Joham, Anju E.
Mousa, Aya
Teede, Helena
author_sort Rassie, Kate
collection PubMed
description CONTEXT: Pre-clinical evidence suggests that prolactin has important metabolic functions in pregnancy and postpartum, in addition to lactogenic actions. OBJECTIVE: To explore the relationship between prolactin and maternal metabolic outcomes in human pregnancy and postpartum, particularly in relation to gestational diabetes mellitus (GDM). DATA SOURCES: MEDLINE via OVID, CINAHL plus, Embase. STUDY SELECTION: Eligible studies included women who were pregnant or up to 12 months postpartum, reporting at least one maternal serum prolactin level in relation to key metabolic outcomes including GDM, glycaemic parameters, obesity, and gestational weight gain. DATA EXTRACTION: Two independent reviewers extracted data. DATA SYNTHESIS: Twenty-six articles were included. Meta-analysis showed no relationship between maternal prolactin levels and GDM status, with a weighted mean difference of -2.14 ng/mL (95% CI -12.54 to 8.27 ng/mL, p=0.7) between GDM and controls in early pregnancy (n=3 studies) and -3.89 ng/mL (95% CI, -15.20 to 7.41 ng/mL, p=0.5) in late pregnancy (n=11 studies). In narrative synthesis of other outcomes (due to study heterogeneity and/or lack of data), prolactin levels were not associated with maternal glycaemic or weight-related parameters during pregnancy, but in the postpartum period (particularly with lactation) a high-prolactin environment was associated with low circulating insulin and beta-cell function, and increased insulin sensitivity. CONCLUSIONS: Current evidence from human studies does not clearly support a relationship between prolactin and metabolic parameters during pregnancy, including with GDM status. Elevated prolactin was associated with lower insulin and beta-cell function and higher insulin sensitivity in the post-partum period, but the direction of causality remains unclear. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier [CRD42021262771].
format Online
Article
Text
id pubmed-9813437
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98134372023-01-06 Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis Rassie, Kate Giri, Rinky Joham, Anju E. Mousa, Aya Teede, Helena Front Endocrinol (Lausanne) Endocrinology CONTEXT: Pre-clinical evidence suggests that prolactin has important metabolic functions in pregnancy and postpartum, in addition to lactogenic actions. OBJECTIVE: To explore the relationship between prolactin and maternal metabolic outcomes in human pregnancy and postpartum, particularly in relation to gestational diabetes mellitus (GDM). DATA SOURCES: MEDLINE via OVID, CINAHL plus, Embase. STUDY SELECTION: Eligible studies included women who were pregnant or up to 12 months postpartum, reporting at least one maternal serum prolactin level in relation to key metabolic outcomes including GDM, glycaemic parameters, obesity, and gestational weight gain. DATA EXTRACTION: Two independent reviewers extracted data. DATA SYNTHESIS: Twenty-six articles were included. Meta-analysis showed no relationship between maternal prolactin levels and GDM status, with a weighted mean difference of -2.14 ng/mL (95% CI -12.54 to 8.27 ng/mL, p=0.7) between GDM and controls in early pregnancy (n=3 studies) and -3.89 ng/mL (95% CI, -15.20 to 7.41 ng/mL, p=0.5) in late pregnancy (n=11 studies). In narrative synthesis of other outcomes (due to study heterogeneity and/or lack of data), prolactin levels were not associated with maternal glycaemic or weight-related parameters during pregnancy, but in the postpartum period (particularly with lactation) a high-prolactin environment was associated with low circulating insulin and beta-cell function, and increased insulin sensitivity. CONCLUSIONS: Current evidence from human studies does not clearly support a relationship between prolactin and metabolic parameters during pregnancy, including with GDM status. Elevated prolactin was associated with lower insulin and beta-cell function and higher insulin sensitivity in the post-partum period, but the direction of causality remains unclear. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier [CRD42021262771]. Frontiers Media S.A. 2022-12-22 /pmc/articles/PMC9813437/ /pubmed/36619539 http://dx.doi.org/10.3389/fendo.2022.1069625 Text en Copyright © 2022 Rassie, Giri, Joham, Mousa and Teede https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Rassie, Kate
Giri, Rinky
Joham, Anju E.
Mousa, Aya
Teede, Helena
Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
title Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
title_full Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
title_fullStr Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
title_full_unstemmed Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
title_short Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
title_sort prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: a systematic review and meta-analysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813437/
https://www.ncbi.nlm.nih.gov/pubmed/36619539
http://dx.doi.org/10.3389/fendo.2022.1069625
work_keys_str_mv AT rassiekate prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis
AT giririnky prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis
AT johamanjue prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis
AT mousaaya prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis
AT teedehelena prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis